Literature DB >> 31954069

Air pollution, a possible risk factor for multiple sclerosis.

Ülkü Türk Börü1, Cem Bölük1,2, Mustafa Taşdemir3, Tuğçe Gezer4, Vedat Ataman Serim5.   

Abstract

OBJECTIVE: Studies focusing attention on the effects of environmental pollution on the etiology of multiple sclerosis (MS) are on the increase. The aim of this study was to determine MS prevalence in a city home to an iron and steel factory which causes air pollution.
METHODS: The study was designed as a cross-sectional, population-based, descriptive epidemiologic study. Ereğli city, which has an iron and steel factory and proven air pollution, was screened. Additionally, Devrek city, which is a rural and clean city, located 40 km away from Ereğli was assigned and results were compared. A validated questionnaire was used for screening. McDonald 2010 criteria were used to diagnose cases.
RESULTS: 32 261 people were screened in Ereğli, and 21 963 people were screened in Devrek. In total, 41 patients were diagnosed with clinical definite MS. Crude prevalence was found to be 96.1/100 000 in Ereğli and 45.5/100 000 in Devrek. The mean age of patients was 39.8, and the female/male ratio was 1.9.
CONCLUSION: The results of this study indicate a more than double MS prevalence rate in the area home to an iron and steel factory when compared to the rural city. This supports the hypothesis that air pollution may be a possible etiological factor in MS.
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Turkey; air pollution; community-based study; epidemiology; multiple sclerosis

Year:  2020        PMID: 31954069     DOI: 10.1111/ane.13223

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  9 in total

1.  Air pollution linked to multiple sclerosis and stroke.

Authors:  Sarah Lemprière
Journal:  Nat Rev Neurol       Date:  2020-03       Impact factor: 42.937

Review 2.  Toxic Air Pollutants and Their Effect on Multiple Sclerosis: A Review Study.

Authors:  Mohammad Javad Mohammadi; Kourosh Zarea; Nasser Hatamzadeh; Arash Salahshouri; Asaad Sharhani
Journal:  Front Public Health       Date:  2022-07-06

3.  Frequency of Neurological Diseases After COVID-19, Influenza A/B and Bacterial Pneumonia.

Authors:  Pardis Zarifkar; Costanza Peinkhofer; Michael E Benros; Daniel Kondziella
Journal:  Front Neurol       Date:  2022-06-23       Impact factor: 4.086

Review 4.  Environmental pollutants and the immune response.

Authors:  Takafumi Suzuki; Takanori Hidaka; Yoshito Kumagai; Masayuki Yamamoto
Journal:  Nat Immunol       Date:  2020-10-12       Impact factor: 25.606

Review 5.  Air Pollution and Central Nervous System Disease: A Review of the Impact of Fine Particulate Matter on Neurological Disorders.

Authors:  Hyunyoung Kim; Won-Ho Kim; Young-Youl Kim; Hyun-Young Park
Journal:  Front Public Health       Date:  2020-12-16

Review 6.  Genetic, Environmental and Lifestyle Determinants of Accelerated Telomere Attrition as Contributors to Risk and Severity of Multiple Sclerosis.

Authors:  Michael Hecker; Jan Bühring; Brit Fitzner; Paulus Stefan Rommer; Uwe Klaus Zettl
Journal:  Biomolecules       Date:  2021-10-13

Review 7.  Pregnancy History, Oral Contraceptive Pills Consumption (OCPs), and Risk of Multiple Sclerosis: A Systematic Review and Meta-Analysis.

Authors:  Mahsa Ghajarzadeh; Aida Mohammadi; Zahra Shahraki; Mohammad Ali Sahraian; Mehdi Mohammadifar
Journal:  Int J Prev Med       Date:  2022-06-24

8.  Systematic literature review and meta-analysis of the prevalence of secondary progressive multiple sclerosis in the USA, Europe, Canada, Australia, and Brazil.

Authors:  Vijayalakshmi Vasanthaprasad; Vivek Khurana; Sreelatha Vadapalle; Jackie Palace; Nicholas Adlard
Journal:  BMC Neurol       Date:  2022-08-17       Impact factor: 2.903

Review 9.  Recent Progress of Toxic Gas Sensors Based on 3D Graphene Frameworks.

Authors:  Qichao Dong; Min Xiao; Zengyong Chu; Guochen Li; Ye Zhang
Journal:  Sensors (Basel)       Date:  2021-05-13       Impact factor: 3.576

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.